Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Fritsche

Showing results (141-150 of 214) with videos related to

Pageof 22
Sort By:
Diagnostic Microbiology and Infectious Disease|September 12, 2003
Susceptibility trends of haemophilus influenzae and Moraxella catarrhalis against orally administered antimicrobial agents: five-year report from the SENTRY Antimicrobial Surveillance ProgramD M Johnson, H S Sader, T R Fritsche, et al.
Journal of Clinical Microbiology|July 11, 2006
Selection of a surrogate agent (vancomycin or teicoplanin) for initial susceptibility testing of dalbavancin: results from an international antimicrobial surveillance programRonald N Jones, Helio S Sader, Thomas R Fritsche, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 21, 2005
Emerging metallo-beta-lactamase-mediated resistances: a summary report from the worldwide SENTRY antimicrobial surveillance programThomas R Fritsche, Helio S Sader, Mark A Toleman, et al.
Applied and Environmental Microbiology|January 5, 1999
In situ detection of novel bacterial endosymbionts of Acanthamoeba spp. phylogenetically related to members of the order RickettsialesT R Fritsche, M Horn, S Seyedirashti, et al.
Diagnostic Microbiology and Infectious Disease|January 24, 2006
Spectrum and potency of dalbavancin tested against 3322 Gram-positive cocci isolated in the United States Surveillance Program (2004)Ronald N Jones, Matthew G Stilwell, Helio S Sader, et al.
The Journal of Antimicrobial Chemotherapy|June 11, 2004
Doripenem (S-4661), a novel carbapenem: comparative activity against contemporary pathogens including bactericidal action and preliminary in vitro methods evaluationsRonald N Jones, Holly K Huynh, Douglas J Biedenbach, et al.
International Journal of Systematic and Evolutionary Microbiology|September 17, 2005
'Candidatus Protochlamydia amoebophila', an endosymbiont of Acanthamoeba sppAstrid Collingro, Elena R Toenshoff, Michael W Taylor, et al.
Diagnostic Microbiology and Infectious Disease|March 21, 2007
Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: a report from the SENTRY antimicrobial surveillance programLalitagauri M Deshpande, Thomas R Fritsche, Gary J Moet, et al.
Journal of Clinical Microbiology|January 12, 2007
Activity of dalbavancin tested against Staphylococcus spp. and beta-hemolytic Streptococcus spp. isolated from 52 geographically diverse medical centers in the United StatesDouglas J Biedenbach, James E Ross, Thomas R Fritsche, et al.
The Journal of Antimicrobial Chemotherapy|November 27, 2004
Initial results from a longitudinal international surveillance programme for anidulafungin (2003)Shawn A Messer, Jeffrey T Kirby, Helio S Sader, et al.
Pageof 22

Showing results (141-150 of 214) with videos related to

Sort By:
Pageof 22
Diagnostic Microbiology and Infectious Disease|September 12, 2003
Susceptibility trends of haemophilus influenzae and Moraxella catarrhalis against orally administered antimicrobial agents: five-year report from the SENTRY Antimicrobial Surveillance ProgramD M Johnson, H S Sader, T R Fritsche, et al.
Journal of Clinical Microbiology|July 11, 2006
Selection of a surrogate agent (vancomycin or teicoplanin) for initial susceptibility testing of dalbavancin: results from an international antimicrobial surveillance programRonald N Jones, Helio S Sader, Thomas R Fritsche, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 21, 2005
Emerging metallo-beta-lactamase-mediated resistances: a summary report from the worldwide SENTRY antimicrobial surveillance programThomas R Fritsche, Helio S Sader, Mark A Toleman, et al.
Applied and Environmental Microbiology|January 5, 1999
In situ detection of novel bacterial endosymbionts of Acanthamoeba spp. phylogenetically related to members of the order RickettsialesT R Fritsche, M Horn, S Seyedirashti, et al.
Diagnostic Microbiology and Infectious Disease|January 24, 2006
Spectrum and potency of dalbavancin tested against 3322 Gram-positive cocci isolated in the United States Surveillance Program (2004)Ronald N Jones, Matthew G Stilwell, Helio S Sader, et al.
The Journal of Antimicrobial Chemotherapy|June 11, 2004
Doripenem (S-4661), a novel carbapenem: comparative activity against contemporary pathogens including bactericidal action and preliminary in vitro methods evaluationsRonald N Jones, Holly K Huynh, Douglas J Biedenbach, et al.
International Journal of Systematic and Evolutionary Microbiology|September 17, 2005
'Candidatus Protochlamydia amoebophila', an endosymbiont of Acanthamoeba sppAstrid Collingro, Elena R Toenshoff, Michael W Taylor, et al.
Diagnostic Microbiology and Infectious Disease|March 21, 2007
Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: a report from the SENTRY antimicrobial surveillance programLalitagauri M Deshpande, Thomas R Fritsche, Gary J Moet, et al.
Journal of Clinical Microbiology|January 12, 2007
Activity of dalbavancin tested against Staphylococcus spp. and beta-hemolytic Streptococcus spp. isolated from 52 geographically diverse medical centers in the United StatesDouglas J Biedenbach, James E Ross, Thomas R Fritsche, et al.
The Journal of Antimicrobial Chemotherapy|November 27, 2004
Initial results from a longitudinal international surveillance programme for anidulafungin (2003)Shawn A Messer, Jeffrey T Kirby, Helio S Sader, et al.
Pageof 22